References
- Friedman JM. Neurofibromatosis 1. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® University of Washington, Seattle; 1993.
- Le C, Bedocs PM. Neurofibromatosis. In: StatPearls Publishing; 2021.
- Denayer E, Legius E. Neurofibromatosis Type 1-Noonan Syndrome: What's the Link? Noonan Syndrome and Related Disorders - A Matter of Deregulated Ras Signaling 2009;17:128–137.
- Allanson JE, Hall JG, Van Allen MI. Noonan phenotype associated with neurofibromatosis. Am J Med Genet 1985;21(3):457–462.
- Carey JC. Neurofibromatosis-Noonan syndrome. Am J Med Genet 1998;75(3):263–264.
- Yapijakis C, Pachis N, Natsis S, Voumvourakis C. Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors? In Vivo 2016;30(3):315–320.
- Bertola DR, Pereira AC, Passetti F, et al. Neurofibromatosis–Noonan syndrome: Molecular evidence of the concurrence of both disorders in a patient. American Journal of Medical Genetics Part A 2005;136A(3):242–245.
- Nyström AM, Ekvall S, Allanson J, et al. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. Clin Genet 2009;76(6):524–534.
- Colley A, Donnai D, Evans DG. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 1996;49(2):59–64.
- De Luca A, Bottillo I, Sarkozy A, et al. NF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan Syndrome. The American Journal of Human Genetics 2005;77(6):1092–1101.
- Thiel C, Wilken M, Zenker M, et al. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Am J Med Genet A 2009;149A(6):1263–1267.
- Terzi Y, Kesikli B, Serdaroglu E, et al. Absence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2011;27:2113–2116.
- Incecik F, Hergüner ÖM, Alınç Erdem S, Altunbaşak Ş. Neurofibromatosis type 1 and cardiac manifestations. Turk Kardiyol Dern Ars 2015;43(8):714–716.
- Friedman JM, Arbiser J, Epstein JA, et al. Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force. Genet Med 2002;4(3):105–111.
- Finley JL, Dabbs DJ. Renal vascular smooth muscle proliferation in neurofibromatosis. Hum Pathol 1988;19(1):107–110.
- Sharma JB, Gulati N, Malik S. Maternal and perinatal complications in neurofibromatosis during pregnancy. Int J Gynaecol Obstet 1991;34(3):221–227.
- Rothner AD, Moodley M, Mientkiewicz L, Erenberg F. Congenital Heart Disease In Neurofibromatosis-1 (P2.225). Neurology 2015;84(14 Supplement).
- Lin AE, Birch PH, Korf BR, et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet 2000;95(2):108–117.
- Tedesco M, Di salvo G, Natale F, et al. The heart in neurofibromatosis type 1: An echocardiographic study. American heart journal 2002;143:883–888.
- Fitzpatrick AP, Emanuel RW. Familial neurofibromatosis and hypertrophic cardiomyopathy. Heart 1988;60(3):247–251.
- Jurko A, Minarik M, Minarikova E, Nagi A. Neurofibromatosis associated with hypertrophic cardiomyopathy. Saudi medical journal 2010;31:935–936.
- Debonnaire P, De BO, De GF, Delanote J, Vandekerckhove Y, Muyldermans L. Multimodality Imaging of Cardiac Involvement in Neurofibromatosis. Journal of the American College of Cardiology 2011;57(17):e209–e209.
- Calcagni G, Limongelli G, D’Ambrosio A, et al. Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results. Int J Cardiol 2017;245:92–98.
- Linglart L, Gelb BD. Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment. Am J Med Genet C Semin Med Genet 2020;184(1):73–80.
- Prendiville TW, Gauvreau K, Tworog-Dube E, et al. Cardiovascular disease in Noonan syndrome. Arch Dis Child 2014;99(7):629–634.
- Kouz K, Lissewski C, Spranger S, et al. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation. Genet Med 2016;18(12):1226–1234.
- Colquitt JL, Noonan JA. Cardiac findings in Noonan syndrome on long-term follow-up. Congenit Heart Dis 2014;9(2):144–150.
- 2020 ESC Guidelines for the management of adult congenital heart disease | European Heart Journal | Oxford Academic.
- 2018 ESC/ESH Guidelines for the management of arterial hypertension | European Heart Journal | Oxford Academic.